Clinof Uses

How do you administer this medicine?
sponsored

What is Clinof?

Clinof belongs to the family of medicines called antibiotics.

Topical Clinof is used to help control acne. It may be used alone or with one or more other medicines that are used on the skin or taken by mouth for acne.

Topical Clinof may also be used for other problems as determined by your doctor.

Clinof is available only with your doctor's prescription.

Clinof indications

An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.
sponsored

Clinof (Clinof palmitate HCl) is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria.

Clinof is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of colitis, as described in the WARNING box, before selecting Clinof the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin).

Anaerobes: Serious respiratory tract infections such as empyema, anaerobic pneumonitis and lung abscess; serious skin and soft tissue infections; septicemia; intra-abdominal infections such as peritonitis and intra-abdominal abscess (typically resulting from anaerobic organisms resident in the normal gastrointestinal tract); infections of the female pelvis and genital tract such as endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis and postsurgical vaginal cuff infection.

Streptococci: Serious respiratory tract infections; serious skin and soft tissue infections.

Staphylococci: Serious respiratory tract infections; serious skin and soft tissue infections.

Pneumococci: Serious respiratory tract infections.

Bacteriologic studies should be performed to determine the causative organisms and their susceptibility to Clinof.

In Vitro Susceptibility Testing

A standardized disk testing procedure2 is recommended for determining susceptibility of aerobic bacteria to Clinof. A description is contained in the Clinof® Susceptibility Disk (Clinof) insert. Using this method, the laboratory can designate isolates as resistant, intermediate, or susceptible. Tube or agar dilution methods may be used for both anaerobic and aerobic bacteria. When the directions in the Clinof® Susceptibility Powder insert are followed, an MIC (minimal inhibitory concentration) of 1.6 mcg/mL may be considered susceptible; MICs of 1.6 to 4.8 mcg/mL may be considered intermediate and MICs greater than 4.8 mcg/mL may be considered resistant.

Clinof Susceptibility Disks 2 mcg. See package insert for use.

Clinof Susceptibility Powder 20 mg. See package insert for use.

For anaerobic bacteria the minimal inhibitory concentration (MIC) of Clinof can be determined by agar dilution and broth dilution (including microdilution) techniques. If MICs are not determined routinely, the disk broth method is recommended for routine use. THE KIRBY-BAUER DISK DIFFUSION METHOD AND ITS INTERPRETIVE STANDARDS ARE NOT RECOMMENDED FOR ANAEROBES.

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Clinof and other antibacterial drugs, Clinof should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

How should I use Clinof?

Use Clinof cream as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Ask your health care provider any questions you may have about how to use Clinof cream.

Uses of Clinof in details

There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.
sponsored

Use: Labeled Indications

Bone and joint infections: Treatment of bone and joint infections, including acute hematogenous osteomyelitis caused by Staphylococcus aureus and as adjunctive therapy in the surgical treatment of chronic bone and joint infections caused by susceptible organisms.

Gynecological infections: Treatment of gynecologic infections, including endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis, and postsurgical vaginal cuff infection caused by susceptible anaerobes.

Intraabdominal infections: Treatment of intraabdominal infections, including peritonitis and intraabdominal abscess caused by susceptible anaerobic organisms.

Lower respiratory tract infections: Treatment of lower respiratory tract infections, including pneumonia, empyema, and lung abscess caused by susceptible anaerobes, Streptococcus pneumoniae, other streptococci (except Enterococcus faecalis), and S. aureus.

Septicemia: Treatment of septicemia caused by S. aureus, streptococci (except E. faecalis), and susceptible anaerobes.

Skin and soft tissue infection: Treatment of skin and soft tissue infection caused by Streptococcus pyogenes, S. aureus, and susceptible anaerobes.

Off Label Uses

Anthrax

Based on the Centers for Disease Control and Prevention (CDC) expert panel meetings on prevention and treatment of anthrax in adults, Clinof is an effective and acceptable alternative for postexposure prophylaxis or treatment of cutaneous anthrax; it is also a first-line option, in combination with other antimicrobials, for the treatment of systemic anthrax. Alternative regimens have also been suggested for other patient populations with anthrax, including injectable drug users who develop injectional anthrax.

Streptococcal (group A) pharyngitis and chronic carriage

Based on the IDSA guidelines for the diagnosis and management of group A streptococcal pharyngitis, Clinof is an effective and recommended alternative agent for the treatment of streptococcal pharyngitis and an option for treatment of chronic group A streptococcal carriage.

Surgical prophylaxis

Based on the American Society of Health-System Pharmacists (ASHP) clinical practice guidelines for antimicrobial prophylaxis in surgery, Clinof, given as an alternative antibiotic in patients with beta-lactam allergy requiring surgical prophylaxis, is effective and recommended for a number of surgical procedures.

Toxoplasma gondii encephalitis and pneumonitis (treatment/long-term maintenance)

Based on the US Department of Health and Human Services guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents and the American Society of Transplantation Infectious Diseases Community of Practice guidelines on parasitic infections in solid organ transplantation, Clinof (with pyrimethamine and leucovorin) is an effective and recommended alternative regimen for the treatment and long-term maintenance therapy of Toxoplasma gondii encephalitis and pneumonitis.

Clinof description

sponsored

Clinof is a semisynthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent compound lincomycin.

Clinof phosphate is a water soluble ester of Clinof and phosphoric acid.

Clinof phosphate is L-threo-α-D-galacto-Octopyranoside, methyl 7-chloro-6, 7, 8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl] amino]-1-thio-, 2-(dihydrogen phosphate), (2S-trans)-.

The molecular formula is C18H34CIN2O8PS and the molecular weight is 504.96.

Clinof hydrochloride is the hydrated hydrochloride salt of Clinof. Clinof hydrochloride is Methyl 7-chloro-6, 7, 8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-α-D-galacto-octopyranoside monohydrochloride.

Clinof palmitate hydrochloride is a water soluble salt of ester of Clinof and palmitic acid. Clinof palmitate hydrochloride is Methyl 7-chloro-6, 7, 8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-α-D-galacto-octopyranoside 2-palmitate monohydrochloride.

Clinof dosage

sponsored

Clinof Dosage

Generic name: Clinof HYDROCHLORIDE 75mg

Dosage form: capsule

See also:

The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.

If significant diarrhea occurs during therapy, this antibiotic should be discontinued.

Adults: Serious infections – 150 to 300 mg every 6 hours. More severe infections – 300 to 450 mg every 6 hours. Pediatric Patients: Serious infections – 8 to 16 mg/kg/day (4 to 8 mg/lb/day) divided into three or four equal doses. More severe infections – 16 to 20 mg/kg/day (8 to 10 mg/lb/day) divided into three or four equal doses.

To avoid the possibility of esophageal irritation, Clinof HCl Capsules should be taken with a full glass of water.

Serious infections due to anaerobic bacteria are usually treated with Clinof PHOSPHATE® Sterile Solution. However, in clinically appropriate circumstances, the physician may elect to initiate treatment or continue treatment with Clinof HCl Capsules.

In cases of β-hemolytic streptococcal infections, treatment should continue for at least 10 days.

More about Clinof (Clinof)

Consumer resources

Professional resources

Other formulations

Related treatment guides

Clinof interactions

See also:
What other drugs will affect Clinof?

With simultaneous use of Clinof with theophylline, aminophylline, caffeine, there is an increase in their concentration in blood plasma and thus increases the risk of toxic effects.

Erythromycin increases the concentrations of cyclosporine in the blood plasma and may increase the risk of nephrotoxicity.

Drugs that block tubular secretion prolongs T1/2 of erythromycin.

Incompatible with lincomycin, Clinof and chloramphenicol (antagonism).

Clinof reduces the bactericidal action of beta-lactam antibiotics (penicillins, cephalosporins, carbapenems).

With simultaneous use of erythromycin increases the concentration of theophylline.

At the same time receiving chemotherapy, which is carried metabolism in the liver (carbamazepine, valproic acid, hexobarbital, phenytoin, alfentanil, dizopiramid, lovastatin, bromocriptine), may increase the concentration of these drugs in plasma (an inhibitor of microsomal liver enzymes).

IV injection of erythromycin increases the effects of ethanol (accelerating gastric emptying and decrease the duration of alcohol dehydrogenase in the gastric mucosa).

Erythromycin reduces the clearance of triazolam and midazolam and therefore may increase the pharmacological effects of benzodiazepines.

At the same time taking with terfenadine or astemizole may develop arrhythmias (fibrillation and ventricular flutter, ventricular tachycardia, until death); with dihydroergotamine or non hydrated ergot alkaloids may vasoconstriction to spasm, dysesthesia.

With simultaneous application Clinof slows elimination (increases the effect) of methylprednisolone, felodipine and anticoagulants of cumarine series.

In a joint appointment with lovastatin increased rhabdomyolysis.

Erythromycin increases the bioavailability of digoxin.

Erythromycin reduces the effectiveness of hormonal contraceptives.

Clinof side effects

See also:
What are the possible side effects of Clinof?

Clinical Trials Experience

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.

A total of 439 subjects with mild to moderate acne vulgaris were treated once daily for 12 weeks with Clinof Foam.

The incidence of adverse reactions occurring in ≥1% of the subjects in clinical trials comparing Clinof Foam and its vehicle is presented in Table 1.

Table 1: Adverse Reactions Occurring in ≥1% of Subjects

Adverse Reactions Number (%) of Subjects
Clinof Foam

N = 439

Vehicle Foam

N = 154

Headache 12 (3%) 1 (1%)
Application site burning 27 (6%) 14 (9%)
Application site pruritus 5 (1%) 5 (3%)
Application site dryness 4 (1%) 5 (3%)
Application site reaction, not otherwise specified 3 (1%) 4 (3%)

In a contact sensitization study, none of the 203 subjects developed evidence of allergic contact sensitization to Clinof Foam.

Postmarketing Experience

The following adverse reactions have been identified during post approval use of Clinof Foam: application site pain, application site erythema, diarrhea, urticaria, abdominal pain, hypersensitivity, rash, abdominal discomfort, nausea, seborrhea, application site rash, dizziness, pain of skin, colitis (including pseudomembranous colitis), and hemorrhagic diarrhea. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

Abdominal pain and gastrointestinal disturbances, as well as gram-negative folliculitis, have also been reported in association with the use of topical formulations of Clinof.

Orally and parenterally administered Clinof have been associated with severe colitis, which may end fatally.

Clinof contraindications

See also:
What is the most important information I should know about Clinof?

You should not use this medication if you are allergic to Clinof or lincomycin (Bactramycin, L-Mycin, Lincocin).

Do not take Clinof together with erythromycin (E.E.S., EryPed, Ery-Tab, Erythrocin, Pediazole, and others).

Before using Clinof, tell your doctor if you have kidney disease, liver disease, an intestinal disorder such as colitis or Crohn's disease, or a history of asthma, eczema, or allergic skin reaction.

Take this medicine for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared. Skipping doses may also increase your risk of further infection that is resistant to antibiotics. Clinof will not treat a viral infection such as the common cold or flu.

Antibiotic medicines can cause diarrhea, which may be a sign of a new infection. If you have diarrhea that is watery or bloody, stop taking Clinof and call your doctor. Do not use anti-diarrhea medicine unless your doctor tells you to.

To be sure this medication is not causing harmful effects, your blood may need to be tested often. Your kidney or liver function may also need to be tested. Visit your doctor regularly.

If you need surgery, tell the surgeon ahead of time that you are using Clinof. You may need to stop using the medicine for a short time.



Active ingredient matches for Clinof:

Clindamycin in India.

Clindamycin Topical


Unit description / dosage (Manufacturer)Price, USD
Clinof 1% w/w GEL / 20g$ 0.87
1 % w/w x 20g$ 0.87
Clinof Skin 20 gm Gel$ 0.87
CLINOF GEL 1 tube / 20 GM gel each (Intermed Pharma Pvt Ltd)$ 0.85
CLINOF topical gel 1 % w/w x 20g (Intermed)$ 1.03
Clinof NA Gel (Intermed Pharma Pvt Ltd)$ 0.85

List of Clinof substitutes (brand and generic names):

CLINMIFACE GEL 1 tube / 15 GM gel each (Prism Life Sciences Ltd)$ 1.43
Clinott -P 150 mg/1 mL x 2 mL (MacroPhar)
Clinott -P 150 mg/1 mL x 4 mL (MacroPhar)
Clinott 150 mg x 10 x 10's (MacroPhar)
Clinott 300 mg x 10 x 10's (MacroPhar)
Clinott cap 150 mg 10 x 10's (MacroPhar)
Clinott cap 300 mg 10 x 10's (MacroPhar)
Clinott-P inj 150 mg/mL 2 mL x 1's (MacroPhar)
Clinott-P inj 150 mg/mL 4 mL x 1's (MacroPhar)
Clinott-P inj 150 mg/mL 6 mL x 1's (MacroPhar)
Clinox 1% w/w T-GEL / 10g (Will Impex)$ 0.63
CLINOX topical gel 1 % w/w x 10g (Will Impex)$ 0.63
Clinox-N Clindamycin 1 % w/w, nicotinamide 4 % w/w. T-GEL / 15g (Will Impex)$ 1.19
CLINOX-N topical gel 15g (Will Impex)$ 1.19
CLINOXID 1% GEL 1 tube / 15 GM gel each (Ajanta)$ 5.16
CLINOXID 2.5% CREAM 1 tube / 15 GM cream each (Ajanta)$ 3.94
CLINOXID topical gel 15g (Ajanta)$ 5.16
Clinred 1% T-GEL / 20g (Encore)$ 1.41
CLINRED GEL 1 tube / 20 GM gel each (Encore)$ 1.41
CLINRED topical gel 1 % x 20g (Encore)$ 1.41
Clinred 1% w/w Gel (Encore)$ 1.54
Clinrik 1% w/w Gel (Mascot Health Series Pvt Ltd)$ 1.44
Clinrik N Gel (Mascot Health Series Pvt Ltd)$ 1.54
Clinscar 1% w/w GEL / 10g (Intra Labs India Pvt Ltd)$ 0.71
1 % w/w x 10g (Intra Labs India Pvt Ltd)$ 0.71
Clinscar Skin 10 gm Gel (Intra Labs India Pvt Ltd)$ 0.71
CLINSCAR topical gel 1 % w/w x 15g (Intra Labs India Pvt Ltd)$ 0.95
CLINSCAR lotion 1 % w/v x 25ml (Intra Labs India Pvt Ltd)$ 1.19
CLINSCAR CAP cap 300 mg x 10's (Intra Life (Cutis))$ 3.02
Clinsof 150mg CAP / 4 (East West Pharma)$ 1.57
Clinsof 300mg CAP / 4 (East West Pharma)$ 2.22
150 mg x 4's (East West Pharma)$ 1.57
300 mg x 4's (East West Pharma)$ 2.22
Clinsof 300 mg Capsule (East West Pharma)$ 0.56
Clinsof 150 mg Capsule (East West Pharma)$ 0.39
CLINSOF cap 150 mg x 4's (East West Pharma)$ 1.57
CLINSOF cap 300 mg x 4's (East West Pharma)$ 2.22
Clinsure 300 mg Capsule (B B Remedies (P) Ltd)$ 0.40
Clinton 300mg x 2mL AMP / 1 (Sympar Lifesciences)
Clinton 600mg x 4mL AMP / 1 (Sympar Lifesciences)
Clinton 300 mg Injection (Sympar Lifesciences)$ 0.67
Clinton 600 mg Injection (Sympar Lifesciences)$ 0.67

References

  1. PubChem. "clindamycin". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
  2. DrugBank. "clindamycin". http://www.drugbank.ca/drugs/DB01190 (accessed September 17, 2018).
  3. MeSH. "Protein Synthesis Inhibitors". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Clinof are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Clinof. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported useful

No survey data has been collected yet


Consumer reported price estimates

No survey data has been collected yet


Consumer reported time for results

No survey data has been collected yet


Consumer reported age

No survey data has been collected yet


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 14 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2022 ndrugs.com All Rights Reserved